superpotent topical steroids
Showing 1 - 25 of 5,153
Bullous Pemphigoid Trial in Montpellier (clobetasol propionate + Methotrexate, clobetasol propionate alone)
Completed
- Bullous Pemphigoid
- clobetasol propionate + Methotrexate
- clobetasol propionate alone
-
Montpellier, FranceUniversity Hospital Of Montpellier
Jan 24, 2022
Descemet Stripping Automated Endothelial Keratoplasty (DSAEK), Descemet Membrane Endothelial Keratoplasty (DMEK) Trial
Recruiting
- Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
- Descemet Membrane Endothelial Keratoplasty (DMEK)
- Nepafenac Ophthalmic
- Dexamethasone Ophthalmic
-
Oslo, NorwayDepartment of Ophthalmology, Oslo University Hospital
Nov 26, 2022
Bullous Pemphigoid Trial in Nice, Marseille, Montpellier (Avdoralimab (IPH5401), Control)
Recruiting
- Bullous Pemphigoid
- Avdoralimab (IPH5401)
- Control
-
Nice, Alpes-Maritimes, France
- +3 more
Feb 18, 2022
Adrenal Insufficiency in Eosinophilic Esophagitis on Chronic
Recruiting
- Eosinophilic Esophagitis
- Cortisol level
-
Aurora, ColoradoUniversity of Colorado Anschutz
Aug 12, 2022
Vulvar Lichen Sclerosus Trial in Mobile (MonaLisa Touch, Topical steroid)
Recruiting
- Vulvar Lichen Sclerosus
- MonaLisa Touch
- Topical steroid
-
Mobile, Alabama
- +1 more
May 19, 2022
Cataract Surgery Trial (Nepafenac Ophthalmic, Dexamethasone Ophthalmic)
Recruiting
- Cataract Surgery
- Nepafenac Ophthalmic
- Dexamethasone Ophthalmic
-
Oslo, NorwayDepartment of Ophthalmology, Oslo University Hospital
Nov 26, 2022
Radiation Dermatitis Trial (Bacterial decolonization, Mometasone furoate 0.1% cream, Bacterial decolonization and Mometasone
Not yet recruiting
- Radiation Dermatitis
- Bacterial decolonization
- +2 more
- (no location specified)
Aug 16, 2022
Eosinophilic Esophagitis Trial in Cleveland (Fluticasone Propionate, Budesonide)
Recruiting
- Eosinophilic Esophagitis
- Fluticasone Propionate
- Budesonide
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Jul 1, 2022
Eosinophilic Esophagitis Trial in Chicago (Dose)
Recruiting
- Eosinophilic Esophagitis
-
Chicago, IllinoisAnn & Robert H Lurie Childjren's Hospital of Chicago
Mar 24, 2022
Vitiligo Trial in Alexandria (Autologous mini punch grafting)
Recruiting
- Vitiligo
- Autologous mini punch grafting
-
Alexandria, EgyptAlexandria faculty of medicine
Feb 21, 2021
Keratitis Bacterial Trial in San Francisco, Miami, Madurai (Moxifloxacin Ophthalmic, Difluprednate Ophthalmic, Riboflavin
Recruiting
- Keratitis Bacterial
- Moxifloxacin Ophthalmic
- +3 more
-
San Francisco, California
- +2 more
Dec 1, 2021
Alopecia Areata Trial in Cairo (the optimized sodium valproate-loaded nanospanlastic dispersion, mometasone furoate lotion)
Not yet recruiting
- Alopecia Areata
- the optimized sodium valproate-loaded nanospanlastic dispersion
- mometasone furoate lotion
-
Cairo, EgyptKasralainy Hospital, Dermatology Department
Aug 20, 2021
Ophthalmopathy , Lacrimal System Trial in Sohag (5 mg chloramphenicol, 1 mg dexamethasone sodium phosphate, 0.25 mg tetryzoline
Completed
- Ophthalmopathy , Lacrimal System
- 5 mg chloramphenicol, 1 mg dexamethasone sodium phosphate, 0.25 mg tetryzoline hydrochloride, 2 mg Hydroxypropyl Methyl Cellulose, 10 mg α-tocopherol acetate and 8 mg macrogol 400).
- sodium hyaluronate, polyethylene and propylene glycol based) three times daily for three months
-
Sohag, EgyptSohag University
Sep 3, 2021
Granulomatous Mastitis Trial in Beijing (Compound Betamethasone Injection, Hydrocortisone Butyrate 0.1% Cream)
Recruiting
- Granulomatous Mastitis
- Compound Betamethasone Injection
- Hydrocortisone Butyrate 0.1% Cream
-
Beijing, Beijing, ChinaDepartment of Breast Surgery,Peking Union Medical College Hospit
Dec 1, 2020
Eosinophilic Esophagitis Steroid Safety Study
Recruiting
- Eosinophilic Esophagitis
-
Athens, Greece
- +3 more
Dec 23, 2021
Pemphigoid, Bullous, Adrenal Insufficiency Trial in Bordeaux (clobetasol decreasing measurement)
Not yet recruiting
- Pemphigoid, Bullous
- Adrenal Insufficiency
- clobetasol decreasing measurement
-
Bordeaux, FranceUniversity Hospital of Bordeaux - Hospital Saint André
Nov 17, 2023
Cataract Trial in Northbrook (Dextenza 0.4Mg Ophthalmic Insert, Prednisolone Acetate 1%)
Enrolling by invitation
- Cataract
- Dextenza 0.4Mg Ophthalmic Insert
- Prednisolone Acetate 1%
-
Northbrook, IllinoisWyse Eyecare
Jan 17, 2023
Athletic Injuries, Eczematous Skin Diseases, Skin Avulsion Trial (Hydrating Cream)
Not yet recruiting
- Athletic Injuries
- +2 more
- Hydrating Cream
- (no location specified)
May 14, 2023
Healthy Trial in Sacramento (Desonide 0.05%, Ketoconazole 2%)
Recruiting
- Healthy
- Desonide 0.05%
- Ketoconazole 2%
-
Sacramento, CaliforniaUniversity of California, Davis, Department of Dermatology
Jun 13, 2022
Scar, Hidradenitis Suppurativa Trial (device, procedure, drug)
Not yet recruiting
- Scar
- Hidradenitis Suppurativa
- Triamcinolone Topical
- +2 more
- (no location specified)
Oct 6, 2022
Glaucoma Trial in Glostrup (Voltaren Ophtha 1 mg/ml, GSK, Monopex 1 mg/ml, Théa)
Active, not recruiting
- Glaucoma
- Voltaren Ophtha 1 mg/ml, GSK
- Monopex 1 mg/ml, Théa
-
Glostrup, Capital Region,, DenmarkDepartment of Ophthalmology
Oct 25, 2022
CTCL Trial in New York (StrataCTX® gel)
Recruiting
- CTCL
- StrataCTX® gel
-
New York, New YorkColumbia University Medical Center, Department of Dermatology
Aug 3, 2021
Alopecia Areata Trial in Assiut (Betamethasone Valerate 0.1% Cream, Pentoxifylline, Metformin)
Not yet recruiting
- Alopecia Areata
- Betamethasone Valerate 0.1% Cream
- +2 more
-
Assiut, EgyptAssiut university
Oct 15, 2023
Allergic Conjunctivitis Trial in Andover (Prednisolone Acetate 1%, Prednisolone Acetate 0.12%, Loteprednol Etabonate 0.2%)
Completed
- Allergic Conjunctivitis
- Prednisolone Acetate 1%
- +3 more
-
Andover, MassachusettsOphthalmic Research Associates
Aug 19, 2020